Fenofibrate

This classification denotes an anti-lipidemic agent with the molecular formula C20H21ClO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier U202363UOS, chemically known as propanoic acid, 2-(4-(4-chlorobenzoyl)phenoxy)-2-methyl-, 1-methylethyl ester but generally known as fenofibrate, which bears US NIH Compound Identifier 3339. European Medicines Agency schedules Fenofibrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07576MIG. The term FENOFIBRATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 35, No. 5 1981, List 21). World Health Organization schedules fenofibrate in its Anatomical Therapeutic Chemical (ATC) Classification. FENOFIBRATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule fenofibrate under HS 29189900 and SITC 51396. As of Q4 2014, FENOFIBRATE remains the US FDA Preferred Term for this commodity. Fenofibrate bears US NLM identifiers UMLS ID C0033228 and NCI Concept Code C29047. SMILES: Clc1ccc(C(=O)c2ccc(OC(C)(C)C(=O)OC(C)C)cc2)cc1.